Atrial Fibrillation patients: Don't settle for a life on meds. Seek your Cure!
Don't wanna be here? Send us removal request.
Statistics
We looked inside some of the posts by a-fibfriend and here's what we found interesting.
Average Info
Notes Per Post
0
Likes Per Post
0
Reblog Per Post
0
Reply Per Post
0
Time Between Posts
8 days
Number of Posts By Type
Text
17
Last Seen Tumblr Blogs
Fun Fact
If you dial 1-866-584-6757, you can leave an audio post for your followers.
Text
2025 AF Symposium Live Case: RF/PFA Ablation Using the TactiFlex System
Live From New York It’s Friday Morning!!! Dr. Chinitz had fun introducing his talk with a reference to NBC’s Saturday Night LIVE’s opening. In another Live Case Transmission (Session 4), we watched Dr. Larry Chinitz from NYU Langone Medical Center in New York, NY, perform a catheter ablation for a 79-year-old male with a 20-year history of A-Fib who had never been ablated before. He used a duo…
0 notes
Text
Learn the Basics: Got A-Fib? You're Almost Certainly Magnesium Deficient
Magnesium deficiency is central to creating conditions in the heart that cause Atrial Fibrillation. Therefore, anyone in A-Fib is almost certainly magnesium deficient. Why? It’s now almost impossible to get adequate amounts of magnesium from our diets. Magnesium used to be plentiful in fruits, vegetable and grains, but decades of industrial-scale farming have stripped the soil of minerals like…
0 notes
Text
2025 AF Symposium: Pulsed Field Ablation (PFA) Danger of Hemolysis
A circular catheter for Pulsed Field Ablation Dr. Pierre Jais of the Central Hospital, Bordeaux, France, gave a presentation on the “Safety Considerations with Pulsed Field Ablation—Hemolysis”. Dr. Jais stressed the importance of catheter design for Pulsed Field Ablation. For example, a large amount of current from a circular catheter goes into the blood pool vs. hitting A-Fib signal…
0 notes
Text
2025 AF Symposium: First Human Trial of Nanosecond Pulse Field Ablation
Dr. Vivek Reddy As an energy source, pulsed field ablation (PFA) has generated tremendous excitement as an A-Fib treatment, largely due to its safety benefits. Dr. Vivek Reddy, Director of Electrophysiology for the Mount Sinai Health System, reports on a trial of a variant energy pulse for Pulse Field Ablation, instead of microsecond pulses it uses nanosecond pulses. Microsecond vs Nanosecond…
0 notes
Text
Steve's A-Fib Survival Kit for the Newly Diagnosed: My Top 7 Picks
By Steve S. Ryan, PhD Your first experiences with Atrial Fibrillation have changed your life in a number of ways. As a former A-Fib patient (cured since 1998) I highly recommend these items when first diagnosed with this beast called ‘Atrial Fibrillation’. My Top 5 Recommendations for the Newly Diagnosed These are the products I recommend (and use) along with a good medical dictionary. These…
View On WordPress
0 notes
Text
2025 AF Symposium Live Case: Nanosecond Pulsed Field Ablation
It’s always a big draw when we get to watch a live ablation, in this case, a cutting edge procedure called “Nanosecond Pulsed Field Ablation. The Live Case Transmission (Session 6), featured Dr. Petr Neuzil at Homolka Hospital, Prague, Czech Hospital. While Dr. Neuzil performed the ablation in Prague, Dr. Vivek Reddy of Mount Sinai Medical Center, was at the AF Symposium. He commented on and…
0 notes
Text
Learn the Basics: Medicines, Herbs and Supplements—Does Natural Mean Safer or Better?
By Patti Ryan, based on an article from the National Institutes of Health Nature has been good to us. Nature gave us aspirin and morphine, and other medicines derived from plants. The use of plants as medicines has a long history in the treatment of disease, and plants have played an important role in improving our health. “Natural” vs. “Unnatural” A lot of people believe that when it comes to…
0 notes
Text
2025 AF Symposium Abstract: Predicting and Preventing A-Fib with Insertab Cardiac Monitors
Just a short report this time. The 2025 AF Symposium printed program includes a section of abstracts with short summaries of current AF research. I found Abstract AFS2025-05 of interest as I have a Medtronic Insertable Cardiac Monitor (ICM) myself. Medtronic Insertable Cardiac Monitor (ICM) and transmitter. Dr Lakkireey and his colleagues described The DEFINE Afib study used the Medtronic…
0 notes
Text
2025 AF Symposium: Cases Demonstrating New LAA Closure Device: Two Presentations
Left Atrium Appendage (LAA) closure devices are no longer considered experimental or not proven. It’s encouraging news for A-Fib patients that there are now additional LAA closure devices including the Watchman (Boston Scientific), Laminar (Biosense Webster), and Amulet (Abbott). In his first of two presentations, a prerecorded video, Dr. Vivek Reddy, Director of Electrophysiology for the Mount…
0 notes
Text
Do You 'Like' Your Doctor, Do You 'Connect'?...How it Affects Your Health
The more people like their doctors, the healthier they tend to be. This is what researchers at Massachusetts General Hospital found in a review study where they examined 13 research reports on this subject. Being the “Best in the Field” Isn’t Enough Even if a doctor(s) is the best in their field and an expert in your condition, that may not help you if you don’t communicate well with them and…
0 notes
Text
2025 AF Symposium: Multi-Electrode Catheter for Pulsed Field Ablation
Dr. Pierre Jais of Central Hospital in Bordeaux, France (LYRIC) discussed the importance of catheter design for performing a Pulse Field Ablation (PFA), Advisor HD Grid catheter and Pulsed Field Ablation In particular, efficiency translates into the amount of power which actually goes to the heart tissue. He explained that with a typical circular catheter much of the power goes into the blood and…
0 notes
Text
2025 AF Symposium Challenging Cases: Predicting the Origin of Non-PV Triggers
Dr. Francis Marchlinski Dr. Francis Marchlinski of the University of Pennsylvania, Philadelphia, PA, was introduced as the leading researcher in non-PV triggers to improve the outcome of A-Fib ablation. He began by talking about the case of a 74-year-old woman who developed Paroxysmal A-Fib in 2015. She was treated with the beta blocker Sotalol, then switched to the antiarrhythmic drugs…
0 notes
Text
Learn the Basics: Understanding the ECG/EKG Signal
One of our most popular pages on A-Fib.com is Understanding the ECG/EKG Signal. The post last week about the Vektor Medical vMap system that uses the common ECG to locate non-PV A-Fib triggers made me think it may be time to review the ECG. Every patient with Atrial Fibrillation is familiar with a electrocardiogram, ECG. But most don’t know how to read their ECG signal strip. First, what is an…
0 notes
Text
2025 AF Symposium: How AI Locates A-Fib Non-PVI Triggers
For A-Fib patients, non-Pulmonary Vein (PVs) triggers are especially hard for the electrophysiologist (EP) to locate when performing catheter ablations. That’s where the vMap system is an important advancement for treating Atrial Fibrillation. vMap 3D image from patient’s ECG. At the 2025 AF Symposium, Dr. Anish Amin of the OhioHealth Heart & Vascular Group, Columbus, Ohio gave a presentation…
0 notes
Text
Infographic: A-Fib & Sleep Apnea—The Life-Threatening Risks; Update on GLP-1 Agonists
Updated March 2025: In my new 2025 AF Symposium report, Weight Loss Drugs and A-Fib, Dr. Donna Ryan of Louisiana State University discusses how the new GLP-1 drugs (Ozempic, Mounjaro and Victoza) help A-Fib patients with sleep apnea as well as weight loss. Read my report Weight Loss Drugs and A-Fib. Sleep Apnea is Common Among A-Fib Patients At least 43% of patients with Atrial Fibrillation…
0 notes
Text
2025 AF Symposium New Report: Weight Loss Drugs and A-Fib
Many A-Fib patients are overweight and also suffer from sleep apnea and hypertension. At the 2025 AF Symposium, Dr. Donna Ryan of Louisiana State University, Baton Rouge, Louisiana gave a talk on GLP-1 Agonists and their role in treating A-Fib. She offers insight into how obesity affects a patient’s Atrial Fibrillation. And how today’s GLP-1 agonists (like brand names Ozempic, Mounjaro and…
0 notes
Text
Left Atrial Appendage Closure (LAAC) for A-Fib: The Watchman Works!
It’s known that 90%-95% of Atrial Fibrillation-related clots (and strokes) originate from the Left Atrial Appendage (LAA). Intuitively one would expect that devices which close off the LAA (such as the Boston Scientific Watchman and the Abbott Amplatzer Amulet) would lower the risk of stroke. Indeed, that’s what happens according to recent research. Furthermore, LAA closure devices significantly…
0 notes